Scholars Central

Research articlePublished Sep 2020

Management of Covid-19 in Morocco: What Protocol and What Are the Factors Associated With Early Viral Clearance?

Authors: K Ennibi, Z Kasmy, A Reggad, A Laatiris, Y Aadi, A Nachite, Y Moutmir, Y Akhouad

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Context: Morocco has adopted the protocol combining hydroxychloroquine or chloroquine with azithromycin to treat patients with COVID-19, mainly based on Chinese studies and those of the IHU Mediterranee team in Marseille. The objective of this study is to assess the effectiveness of this association in a Moroccan population. Methods: We conducted a prospective descriptive analytical study at the Center of virology, infectious and tropical diseases to assess the efficacy of hydroxychloroquine associated with azithromycin for the treatment of patients with COVID-19. All patients hospitalized at the Center between March 16, 2020 and June 16, 2020 was included in this study with a positive RT-PCR result for SARS-CoV-2. Results: 186 patients were hospitalized during this period meeting the inclusion criteria. All patients benefited from the combination of hydroxychloroquine and azithromycin. We studied the clinical, biological and CT parameters that could be associated with early viral clearance with a negative RT-PCR on D6 and D8. The average age at diagnosis is 36.29 ± 11.56 years. 182 patients (97.84%) were cured after 10 days of treatment. 51 patients (27.41%) had a viral clearance on D6 and D8. In the univariate analysis, the absence of lymphopenia was significantly associated with early viral clearance (p=0.036). In the multivariate analysis, young age less than 40 years and a normal Lactate Dehydrogenase level were associated with early viral clearance (p=0.014 and p=0.016). Conclusion: Our study did not show early viral clearance in patients treated with the combination of hydroxychloroquine and azithromycin, although clinical healing has been achieved in the majority of patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Infectious Diseases & Therapy
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “K Ennibi”
  • BylineArticles whose byline prints “Z Kasmy”
  • BylineArticles whose byline prints “A Reggad”
  • BylineArticles whose byline prints “A Laatiris”
  • BylineArticles whose byline prints “Y Aadi”
  • BylineArticles whose byline prints “A Nachite”
  • BylineArticles whose byline prints “Y Moutmir”
  • BylineArticles whose byline prints “Y Akhouad”